SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-033034
Filing Date
2020-12-08
Accepted
2020-12-08 19:05:18
Documents
1
Period of Report
2020-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4063
  Complete submission text file 0000899243-20-033034.txt   5595
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address
Tregoning Kathleen (Reporting) CIK: 0001830764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39311 | Film No.: 201376486